An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Floxuridine has been studied across 13 research domains including 🔬 Oncology, 🫁 Liver & Detox, 🫘 Kidney, 😴 Sleep, 🧬 Hormones. The primary research focus is 🔬 Oncology with 77% of studies addressing this area.
This evidence profile for Floxuridine is generated deterministically from 191 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.